Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Avecho Biotechnology Limited

AU$0.013

Price Change Indicator
-0.001 (-7.143%)
Avecho Biotechnology Limited
AVE · ASX

Avecho Biotechnology Limited

Start Trading AVE for Free

AU$0.013

Price Arrow-0.001 (-7.143%)
12/05/2026 02:09:56 PM
All-CompaniesGROWTH AUSHALO OrdsHALO Price MomentumNear 52 Week HighNear Resistance
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Avecho Biotechnology Limited Overview

AVE Health Scores

Short Term

Mean Reversion

Very Weak

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AVE

icon
icon

Telephone

61.3.9002.5000

icon

Address

Unit A8, 2A Westall Road, Clayton, Victoria (VIC) 3168

Description

Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates through the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.

AVE Price Chart

Key Stats

Market Cap

AU$47.85M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0 - 0.01

Trade Value (12mth)

AU$10,785.00

1 week

16.67%

1 month

47.37%

YTD

47.37%

1 year

250%

All time high

0.42

Key Fundamentals

EPS 3 yr Growth

7.70%

EBITDA Margin

-474.00%

Operating Cashflow

$1m

Free Cash Flow Return

45.50%

ROIC

-182.40%

Interest Coverage

-12.70

Quick Ratio

9.90

Other Data

Shares Outstanding (Fully Diluted)

3,426m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AVE Announcements

Latest Announcements

DateAnnouncements
12 May 26
07 May 26
01 May 26
29 April 26
29 April 26

AVE Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklockN/AN/AN/Alocklocklock
EPS (Fully Diluted)
 $locklocklocklockN/AN/AN/Alocklocklock
Growth
 %locklocklocklock-15.433.3-40locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

HALO Consensus Score

PEG Ratio

Consensus EPS Revisions

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVE Shortsell

Related Companies

CSL - ASX
CSL Limited

CSL · ASX

CSL Limited

AU$98.63

Price Change Indicator

-2.12 (-2.104%)

RMD - ASX
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

RMD · ASX

ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

AU$27.56

Price Change Indicator

-1.06 (-3.704%)

SIG - ASX
Sigma Healthcare Ltd

SIG · ASX

Sigma Healthcare Ltd

AU$2.85

Price Change Indicator

0.01 (0.352%)

Want to learn more?Frequently asked questions.
What is the current share price of Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The current share price of Avecho Biotechnology Limited (AVE:ASX) is AUD$0.01.
What is the 52-week high share price for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The 52-week high share price for Avecho Biotechnology Limited (AVE:ASX) is AUD$0.01.
What is the 52-week low share price for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
The 52-week low share price for Avecho Biotechnology Limited (AVE:ASX) is AUD$0.00.
What is the dividend yield for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
What was Avecho Biotechnology Limited (AVE:ASX) last dividend payment?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
What is the franking level for Avecho Biotechnology Limited (AVE:ASX)?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) has a franking level of 0.00%.
In which sector is Avecho Biotechnology Limited (AVE:ASX) classified?
Halo FAQ
Avecho Biotechnology Limited (AVE:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial